These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6722179)

  • 41. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the membrane concanavalin A binding site in platelet-fibrin interactions.
    Chow TW; McIntire LV; Peterson DM
    Biochim Biophys Acta; 1985 Jan; 812(2):512-22. PubMed ID: 3967023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinogen degradation products and fibrinogen to fibrin conversion.
    Arnesen H
    Scand J Haematol Suppl; 1971; 13():245-52. PubMed ID: 5290685
    [No Abstract]   [Full Text] [Related]  

  • 44. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
    Yesudasan S; Wang X; Averett RD
    J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of methylmercuric chloride (MMC) on fibrin polymerization.
    Michalska M; Wierzbicki R
    Biol Trace Elem Res; 1993; 37(2-3):157-64. PubMed ID: 7688529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
    Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
    Cierniewski CS; Janiak A; Wyroba E
    Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of fibrin networks in plasma and fibrinogen solution.
    Shah GA; Nair CH; Dhall DP
    Thromb Res; 1987 Feb; 45(3):257-64. PubMed ID: 3660340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does topology drive fiber polymerization?
    Huang L; Hsiao JP; Powierza C; Taylor RM; Lord ST
    Biochemistry; 2014 Dec; 53(49):7824-34. PubMed ID: 25419972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of the fibrinogen-binding tetrapeptide Gly-Pro-Arg-Pro with fine clots and oligomers of alpha-fibrin; comparisons with alpha beta-fibrin.
    Shimizu A; Schindlauer G; Ferry JD
    Biopolymers; 1988 May; 27(5):775-88. PubMed ID: 3382717
    [No Abstract]   [Full Text] [Related]  

  • 52. Stable complex of fibrinogen and fibrin.
    Sasaki T; Page IH; Shainoff JR
    Science; 1966 May; 152(3725):1069-71. PubMed ID: 5931451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb.
    Jarvis GE; Atkinson BT; Frampton J; Watson SP
    Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Properties of 2 fibrin monomer species which differ in the degree of thrombin activation. Characteristics of successively appearing active sites].
    Lugovskoĭ EV; Gogolinskaia GK; Derzskaia SG; Belitser VA
    Biokhimiia; 1978 Jun; 43(6):1045-53. PubMed ID: 667211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of fibrinogen on fibrin polymerization. Ultracentrifugation studies.
    Preissner KT; Rötker J; Selmayr E; Fasold H; Müller-Berghaus G
    Biochim Biophys Acta; 1985 Jul; 829(3):358-64. PubMed ID: 4005267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrinopeptide B in fibrin assembly and metabolism: physiologic significance in delayed release of the peptide.
    Shainoff JR; Dardik BN
    Ann N Y Acad Sci; 1983 Jun; 408():254-68. PubMed ID: 6575688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA; Budzynski AZ
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.
    Pretorius E; Mbotwe S; Bester J; Robinson CJ; Kell DB
    J R Soc Interface; 2016 Sep; 13(122):. PubMed ID: 27605168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.